Skip to main content
NeuronFeed

Deepull vs Truveta

Which Healthcare AI tool is better in 2026?

Deepull

$56M

Truveta

$515M

Side-by-side

Verdict

Truveta is the more established option (raised $515M); pricing is comparable on both sides.

Metric Deepull Truveta
Taglinei
Foundedi 2020🏆
HQi
Employeesi 11-50 11-50
Neuron scorei 62 75🏆
Total fundingi $56M $515M🏆
Latest roundi Series C Series C · Jan 2025
Valuationi $1B🏆
Cheapest paid plani Pricing not disclosed Pricing not disclosed
Free plani
Free triali
Top tier pricei Pricing not disclosed Pricing not disclosed
Pricing summaryi Free Free
Categoriesi

Capability matrix

Developer-facing capabilities and access signals for Deepull and Truveta.

Capability Deepull Truveta
MCP support
Public API
Webhooks
OAuth 2.0
SDK languages
Free plan
Free trial
Verified
Active deal

🟢 Strengths of Deepull

  • Strong in AI Healthcare

🔵 Strengths of Truveta

  • Has raised more capital ($515M vs $56M)
  • Higher Neuron score (75 vs 62)
  • Newer company (2020)

Which should you choose?

Choose Truveta if price matters most — it starts at Free, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.

Choose Truveta if you want the most established option — it has raised $515M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.

Frequently asked questions

Deepull vs Truveta — which is better?

It depends on your priority. Deepull is the leaner option; Truveta has broader feature depth. See the side-by-side table above.

Is Deepull cheaper than Truveta?

No — Truveta's cheapest paid plan is Free, while Deepull's is Free.

Do Deepull and Truveta offer free plans?

Deepull: Yes, has a free plan. Truveta: Yes, has a free plan.

Contextual paths to related AI startups, deals and rankings.